Detachment of ligands from nanoparticle surface under flow and endothelial cell contact: Assessment using microfluidic devices
暂无分享,去创建一个
Samir Mitragotri | Kapil Pant | Balabhaskar Prabhakarpandian | S. Mitragotri | J. Ott | K. Pant | B. Prabhakarpandian | Maria Jarvis | Michael Arnold | Jenna Ott | Vinu Krishnan | V. Krishnan | Maria I Jarvis | Michael Arnold
[1] Yadong Yin,et al. Colloidal nanocrystal synthesis and the organic–inorganic interface , 2005, Nature.
[2] S. Mitragotri,et al. Synergistic antitumor activity of camptothecin-doxorubicin combinations and their conjugates with hyaluronic acid. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[3] S. Digumarthy,et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology , 2007, Nature.
[4] M. Manimaran,et al. Multi-step microfluidic device for studying cancer metastasis. , 2007, Lab on a chip.
[5] H. Van Swygenhoven,et al. Dimples on Nanocrystalline Fracture Surfaces As Evidence for Shear Plane Formation , 2003, Science.
[6] Rachel W. Kasinskas,et al. A multipurpose microfluidic device designed to mimic microenvironment gradients and develop targeted cancer therapeutics. , 2009, Lab on a chip.
[7] S. Vyas,et al. Ligand-receptor-mediated drug delivery: an emerging paradigm in cellular drug targeting. , 2001, Critical reviews in therapeutic drug carrier systems.
[8] S. Mitragotri,et al. Microfluidic co‐culture devices to assess penetration of nanoparticles into cancer cell mass , 2017, Bioengineering & translational medicine.
[9] Si-Shen Feng,et al. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. , 2005, Biomaterials.
[10] Kapil Pant,et al. Synthetic tumor networks for screening drug delivery systems. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[11] Sidney Yip,et al. Nanocrystals: The strongest size , 1998, Nature.
[12] M. Mayo,et al. Structure and Mechanical Behavior of Bulk Nanocrystalline Materials , 1999 .
[13] M. Laberge,et al. Frictional Behavior of Individual Vascular Smooth Muscle Cells Assessed By Lateral Force Microscopy , 2010, Materials.
[14] D. Irvine,et al. Bio-inspired, bioengineered and biomimetic drug delivery carriers , 2011, Nature Reviews Drug Discovery.
[15] K. Pant,et al. Generation of shear adhesion map using SynVivo synthetic microvascular networks. , 2014, Journal of visualized experiments : JoVE.
[16] Kapil Pant,et al. Microfluidic devices for modeling cell-cell and particle-cell interactions in the microvasculature. , 2011, Microvascular research.
[17] J. Reddy,et al. Folate-targeted chemotherapy. , 2004, Advanced drug delivery reviews.
[18] A Alexander-Katz,et al. Shear-induced unfolding triggers adhesion of von Willebrand factor fibers , 2007, Proceedings of the National Academy of Sciences.
[19] R. Tiwari,et al. Drug delivery systems: An updated review , 2012, International journal of pharmaceutical investigation.
[20] Weihong Tan,et al. Aptamer-enabled efficient isolation of cancer cells from whole blood using a microfluidic device. , 2012, Analytical chemistry.
[21] S. Mitragotri,et al. Synergistic targeting of cell membrane, cytoplasm, and nucleus of cancer cells using rod-shaped nanoparticles. , 2013, ACS nano.
[22] Francesco Stellacci,et al. Effect of surface properties on nanoparticle-cell interactions. , 2010, Small.
[23] T. Allen. Ligand-targeted therapeutics in anticancer therapy , 2002, Nature Reviews Cancer.
[24] B. Ladoux,et al. Dynamics of a tethered polymer in shear flow. , 2000, Physical review letters.
[25] A. Mukherjee,et al. Deformation of nanocrystalline materials by molecular-dynamics simulation: relationship to experiments? , 2005 .
[26] Mauro Ferrari,et al. Intravascular Delivery of Particulate Systems: Does Geometry Really Matter? , 2008, Pharmaceutical Research.
[27] Francesco M Veronese,et al. PEGylation, successful approach to drug delivery. , 2005, Drug discovery today.
[28] R. Kamm,et al. Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function , 2012, Proceedings of the National Academy of Sciences.
[29] Leaf Huang,et al. Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[30] Robert Gurny,et al. Current methods for attaching targeting ligands to liposomes and nanoparticles. , 2004, Journal of pharmaceutical sciences.
[31] S. Zalipsky. Functionalized poly(ethylene glycol) for preparation of biologically relevant conjugates. , 1995, Bioconjugate chemistry.
[32] Hazem Salim Damiri,et al. Numerical design and optimization of hydraulic resistance and wall shear stress inside pressure-driven microfluidic networks. , 2015, Lab on a chip.
[33] R. Langer,et al. Designing materials for biology and medicine , 2004, Nature.
[34] Shuming Nie,et al. Emerging use of nanoparticles in diagnosis and treatment of breast cancer. , 2006, The Lancet. Oncology.
[35] Rainer H Müller,et al. Nanocrystal technology, drug delivery and clinical applications , 2008, International journal of nanomedicine.
[36] P. Davies,et al. Haemodynamic shear stress activates a K+ current in vascular endothelial cells , 1988, Nature.
[37] Weihong Tan,et al. Aptamer-based microfluidic device for enrichment, sorting, and detection of multiple cancer cells. , 2009, Analytical chemistry.
[38] Mark E. Davis,et al. Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.
[39] Gwo-Bin Lee,et al. Microfluidic cell culture systems for drug research. , 2010, Lab on a chip.
[40] E. Frenkel,et al. Nanoparticles for drug delivery in cancer treatment. , 2008, Urologic oncology.
[41] S. Chien,et al. Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. , 2011, Physiological reviews.
[42] Norased Nasongkla,et al. Functionalized Micellar Systems for Cancer Targeted Drug Delivery , 2007, Pharmaceutical Research.
[43] S. Mitragotri,et al. DAFODIL: A novel liposome-encapsulated synergistic combination of doxorubicin and 5FU for low dose chemotherapy. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[44] S. Lai,et al. Evading immune cell uptake and clearance requires PEG grafting at densities substantially exceeding the minimum for brush conformation. , 2014, Molecular pharmaceutics.